Terri Herrian, NP
Adult Health · Norman, OKNPI 1790127397
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$879
- Amgen$873
- Pfizer$484
- Mylan Specialty L.p.$433
- Lilly USA, LLC$381
- AbbVie$368
- plus $3K from 25 others
What the payments were for
- Consulting fees$1753%
- Food & beverage$6,13297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 45 | $879 |
| Amgen | 33 | $873 |
| Pfizer | 28 | $484 |
| Mylan Specialty L.p. | 25 | $433 |
| Lilly USA, LLC | 24 | $381 |
| AbbVie | 14 | $368 |
| AstraZeneca | 20 | $344 |
| Novo Nordisk | 11 | $312 |
| Novartis | 15 | $301 |
| Bayer | 14 | $275 |
| Inogen, Inc. | 16 | $174 |
| Boehringer Ingelheim | 7 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $150 |
| Abbott | 6 | $131 |
| Sumitomo Pharma America, Inc. | 4 | $100 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Dexcom, Inc. | 5 | $95 |
| Astellas Pharma US Inc | 4 | $94 |
| Baxter Healthcare | 4 | $90 |
| Exact Sciences | 5 | $89 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Viatris Specialty LLC | 3 | $63 |
| Merck | 4 | $53 |
| Almatica Pharma LLC | 2 | $46 |
| Verona Pharma, Inc. | 3 | $45 |
| Johnson & Johnson | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Lundbeck LLC | 1 | $21 |
| Philips North America LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$175
- TRELEGY ELLIPTA$117
- RYBELSUS$116
- UBRELVY$116
How this compares
$6,307 in reported general payments places this provider in the 90th percentile of 117 adult health providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 168 | $192,452 |
| OzempicSemaglutide | 121 | $135,262 |
| EliquisApixaban | 88 | $90,510 |
| JardianceEmpagliflozin | 88 | $86,264 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $75,115 |
| VraylarCariprazine Hcl | 39 | $59,003 |
| AuvelityDextromethorphan Hbr/Bupropion | 33 | $32,425 |
| Repatha SureclickEvolocumab | 52 | $31,562 |
| FarxigaDapagliflozin Propanediol | 29 | $31,278 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $30,797 |
| MyrbetriqMirabegron | 40 | $30,720 |
| RybelsusSemaglutide | 19 | $21,826 |
| JanuviaSitagliptin Phosphate | 22 | $21,767 |
| MovantikNaloxegol Oxalate | 33 | $17,327 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $16,582 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $381 | $192,452168 claims |
| Novo NordiskOzempic, Rybelsus | $312 | $157,088140 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta, Synjardy, Jentadueto Xr | $158 | $121,237146 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $879 | $91,697102 claims |
| PfizerEliquis | $484 | $90,51088 claims |
| AbbVieVraylar, Linzess | $368 | $65,59551 claims |
| AstraZenecaFarxiga, Symbicort | $344 | $40,16455 claims |
| Axsome Therapeutics, Inc.Auvelity | $99 | $32,42533 claims |
| Astellas Pharma US IncMyrbetriq | $94 | $30,72040 claims |
| MerckJanuvia | $53 | $21,76722 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $100 | $16,54321 claims |
| Johnson & JohnsonXarelto | $29 | $15,77615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 117 adult health providers in Oklahoma.
Other adult health in Norman
- Laura VelezNorman$5K
- Kelly WhiteNorman$1K
- Cynthia CattaneoOklahoma City$45K
- Melinda MackeyEl Reno$18K
- Miki ThompsonOklahoma City$14K
- Georgianne TokarchikTulsa$12K
- Kellie RohwerOklahoma City$11K
- Terry GreenOklahoma City$9K
- Nissy PhilipOklahoma City$8K
- Kelli AndersonTulsa$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.